{
    "id": "dbpedia_4133_0",
    "rank": 75,
    "data": {
        "url": "https://www.whatisbiotechnology.org/index.php/science/summary/gene",
        "read_more_link": "",
        "language": "en",
        "title": "Gene therapy",
        "top_image": "https://www.whatisbiotechnology.org/assets/images/science/home/gene.jpg",
        "meta_img": "https://www.whatisbiotechnology.org/assets/images/science/home/gene.jpg",
        "images": [
            "https://www.googleadservices.com/pagead/conversion/870754161/?label=AkXcCMzPhnQQ8c6anwM&guid=ON&script=0"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "A leading educational and public engagement platform exploring the people, places and technologies that have enabled biotechnology to transform our healthcare and the world we live in today",
        "meta_lang": "",
        "meta_favicon": "https://www.whatisbiotechnology.org/assets/icons/WiB.ico",
        "meta_site_name": "WhatisBiotechnology.org",
        "canonical_link": "https://www.whatisbiotechnology.org/",
        "text": "The term 'Eugenics' is coined by Francis Galton to denote the science of improving stock by judicious mating\n\nA nucelotide called tuberculinic acid found to bind to the protein tuberculin. It is now regarded as the precursor to the discovery of DNA methylation\n\nT.B. Johnson and R.D. Coghill reported detecting a minor amount of methylated cytosine derivative as byproduct of hyrdrolysis of tuberculinic acid with sulfuric acid but other scientists struggled to replicate their results.\n\nJackson Memorial Laboratories established to develop inbred strains of mice to study the genetics of cancer and other diseases\n\nThe first cogenic line of inbred mouse strains were developed, which helped determine the major histocompatibility complex, a set of genes that code for proteins found on the surfaces of cells which help the immune system recognise foreign substances.\n\nInbred strains of mice bred at Jackson Memorial Laboratory showed that resistance to transplanted tumours were due to body's resistance to genetically different tissue\n\n'Epigenetics' coined as a term to describe how genes interact with the environment to produce the physical traits of an organism\n\nNew technique published for mapping the gene shows genes are linear and cannot be divided\n\nNormal cell population discovered to only be able to divide a limited number of times before it stops\n\nAmerican scientists demonstrate that adding foreign genes to cultured cells from patients with Lesch-Nethan syndrome can correct genetic defects that cause the neurological disease\n\nProto-oncogenes suggested to be part of the genetic machinery of normal cells and play important function in the developing cell\n\nTechnique published using fine glass micropipettes to inject DNA directly into the nuclei of cultured mammalian cells. High efficiency of the method enables investigators to generate transgenic mice containing random insertions of exogenous DNA.\n\nExperiment published demonstrating possibility of inserting a corrective DNA in the right place in genome of mammalian cells\n\nDiscovery of the first zinc finger nuclease, a site-specific endonuclease (enzyme) designed to bind and cleave DNA at specific positions\n\nAdoptive transfer of tumor-infiltrating lymphocytes shown in mice to be 50 to 100 times more effective in therapeutic potency than lymphokine-activated killer cells\n\nGene targeting technique shown to be efficient in modifying DNA in mammalian cells which can be adapted for other systems. This is the first time genome modification appears possible.\n\nFirst use of genetically engineered T cells to redirect T cells to recognise and attack tumour cells\n\nFour year old Ashanti DeSilva becomes first patient successfully treated with gene therapy for severe combined immunodeficiency caused by defective ADA gene\n\nBRCA1, a single gene on chromosome 17, shown to be responsible for many breast and ovarian cancers\n\nGene targeting technology in combination with embryonic stem cells shown to be powerful tool for creating specific genetic mutations in mice so as to study gene function and create animal models of human genetic disease\n\nBreaks made in a double-strand of DNA in a mouse chromosome for the first time using a rare-cutting endonuclease, I-Scel. The method lays the foundation for a new technique for targeted genome modification using double-stranded breaks instead of plasmids.\n\nDeath of the first patient in a gene therapy trial prompted major setback for the field\n\nFirst evidence from mammals that epigenetic changes can be passed down generations\n\nLink identified between genes responsible for neurofibromatosis, a common neurological disorder, and a protein thought to play role in Alzheimer's disease\n\nFirst plant genome modified with Zinc finger method. Illustrates tool can be used to make targeted modifications in experimental organisms for gene functional studies and creating models of human genetic diseases.\n\nZinc finger method reported capable of modifying some genes in the human genome, laying the foundation for its use as tool to correct genes for monogenic disorders\n\nAmerican researchers identified new familes of Cas genes which appeared to help in protecting bacteria against invading viruses\n\nAdoptive cellular therapy using chimeric antigen receptor T cells shown to be safe in small group of patients with ovarian cancer\n\nExperiments demonstrate for the first time the role of CRISPR together with Cas9 genes in protecting bacteria against viruses\n\nScientists coin the term 'protospacer' to denote viral sequence that corresponds to a 'spacer' in the CRISPR-Cas9 system\n\nUS scientists publish a technique for genetically engineering transcription activator-like effectors customised to recognise specific DNA-binding sites which they show is an effective tool for editing mammalian genomes\n\nPatient suffering from acute myeloid leukaemia is cured of HIV-1 after receiving bone marrow stem cells transplanted from donor with mutated CCR5 gene. This awakens interest in developing HIV treatment that renders a patient's cells resistant to HIV-1\n\nCRISPR-Cas is used in genome editing of Saccharomyces cerevisiae, a yeast species used in wine making, baking and brewing\n\nBasic studies conducted with TALENs to see if can correct mutant genes associated with Epidermolysis Bullosa, a rare inherited skin disorder\n\nUS FDA cleared Investigative Drug Application for clinical trial of gene therapy for haemophila B. The therapy was the first in vivo genome editing application to enter the clinic\n\nUS scientists call for a voluntary worldwide moratorium on the use of genome editing tools to modify human reproductive cells\n\nNational Institutes of Health declared it will not fund any use of genome editing technologies in human embryos\n\nUK Nuffield Council on Bioethics launched a new working group to look into institutional, national and international policies and provisions relevant to genome editing\n\nHinxton Group issues a statement indicating that most of the ethical and moral questions raised about CRISPR and gene editing have been debated before\n\nCRISPR/Cas9 modified 60 genes in pig embryos in first step to create organs suitable for human transplants\n\nUNESCOâ€™s International Bioethic Committee called for ban on genetic editing of human germline\n\nFirst oncology gene therapy approved in US and Europe\n\nFirst successful use of gene therapy to treat baby dying from leukaemia\n\nUS scientists published a technique for overwriting changes made by CRISPR/Cas 9\n\nUS scientists genetically modified mosquitos using CRISPR/Cas9 to prevent them carrying malaria parasite\n\nInternational Summit on Human Gene Editing met to discuss the scientific, medical, ethical, and governance issues associated with recent advances in human gene-editing research\n\nPreliminary results presented for phase 2 trial using Zinc finger nuclease modified CD4 and CD8 cells to treat HIV patients\n\nGene editiing tool, CRISPR, successfully used to improve muscle function in mouse model of Duchenne muscular dystrophy\n\nUS scientists published improved version of CRISPR/Cas 9 with less risk of off-target DNA breaks\n\nGene editing used to prompt immune cells to combat cancer\n\nUS scientists publish new base editing technique offering means to alter genome without needing to cleave double-stranded DNA or for a donor DNA template\n\n2016: NIH gives green light for first clinical trial using gene editing tool CRISPR/Cas 9 to treat patients\n\nUS National Academies of Science and Medicine gave green light to proceed with CRISPR in germ-line experiments\n\nGene therapy reported to successfully reverse sickle cell disease in first patient\n\nFirst gene therapy approved in Europe for lipoprotein lipase deficiency (Glybera) withdrawn from market\n\nCRISPR shown to be sensitive diagnostic tool for detecting single target of DNA or RNA molecule\n\nResearch published demonstrating how CRISPR-CAS9 can be used to eliminate HIV in infected mice.\n\nUS FDA Oncologic Drugs Advisory Committee recommended the approval of the first adoptive cell therapy (CAR-T cell therapy) for B cell acute leukaemia\n\nResearch published demonstrating possibility of editing gene defect in pre-implanted human embryos for preventing inherited heart disease\n\nUSA FDA approved CAR-T therapy for certain pediatric and young adult patients with a form of acute lymphoblastic leukemia\n\nDNA of human embryos edited using CRISPR-Cas9 to study cause of infertility\n\nChinese researchers report correction of gene linked to beta thalassaemia, inherited blood disorder, in human embryos using base editing technique\n\nGene therapy shown in clinical trials to halt progression of adrenoleukodystrophy, a fatal brain disease inherited by boys\n\nBase editing improvements announced for CRISPR technique, providing means to change individual chemical letters of DNA without need to cleave DNA\n\nRare mutation of gene called Serpine 1 discovered to protect against biological ageing process\n\nGene therapy shown to be safe and efficacious treatment for haemophilia A in British trials\n\nResearchers identify pre-existing antibodies targeting CAS9 proteins raising possibility of immune responses undermining utility of CRISPR-Cas9 for gene therapy\n\nGene therapy shown to be promising treatment in clinical trials for beta thalassemia\n\nGene therapy approved in Europe for treatment of patients with vision loss linked to genetic mutation\n\nCRISPR-Cas9 used to control genetic inheritance in mice\n\nSecond patient reported free of HIV after receiving stem-cell therapy\n\nGene therapy shown to be promising in treating infants born with X-linked severe combined immunodeficiency (SCID-X1)\n\nWorld Health Organisation called on countries to ban experiments that would lead to more gene-edited babies\n\nNHS introduced new fast-track DNA test to scan for rare diseases in babies and children\n\nChinese scientist convicted for using CRISPR-Cas9 in human babies\n\nMice experiments indicate gene therapy could provide long-lasting protection against different chemical nerve agents\n\nFirst patient received gene editing therapy with CRISPR directly administered into the body\n\nResearch published casting doubt over safety of using CRISPR-Cas 9 to modify human embryos\n\nNobel Prize in Chemistry awarded to Emmanuelle Charpentier and Jennifer Doudna 'for the development of a method for genome editing'.\n\nGene therapy reported to restore immune function in children with rare immunodeficiency\n\nFirst NHS patient treated with gene therapy for spinal muscular atrophy\n\nNew switch method published enabling precise control of gene editing providing means to refine and tailor gene therapies\n\nFDA gives Vertex green light to submit rolling application for review of CRISPR based therapy to treat sickle cell disease and beta thalassemia\n\nSmall clinical trial shows CRISPR promising tool for editing immune cells to enhance their capacity to destroy cancer cells\n\nNew CRISPR gene editing tools found in thousands of phages\n\nWorld's first CRISPRâ€“Cas9 gene editing therapy given conditional approval in UK for two blood disorders\n\nCRISPR gene therapy reported to be promising treatment for inherited vision loss in phase 1/2 trial"
    }
}